Abstract |
Although several reports describe the metabolic fate of sphingoid bases and their analogs, as well as their action and that of their phosphates as regulators of sphingolipid metabolizing- enzymes, similar studies for 3-ketosphinganine (KSa), the product of the first committed step in de novo sphingolipid biosynthesis, have not been reported. In this article we show that 3-ketosphinganine (KSa) and its dideuterated analog at C4 (d2KSa) are metabolized to produce high levels of dihydrosphingolipids in HGC27, T98G and U87MG cancer cells. In contrast, either direct C1 O-phosphorylation or N-acylation of d2KSa to produce dideuterated ketodihydrosphingolipids does not occur. We also show that cells respond to d2KSa treatment with induction of autophagy. Time-course experiments agree with sphinganine, sphinganine 1-phosphate and dihydroceramides being the mediators of autophagy stimulated by d2KSa. Enzyme inhibition studies support that inhibition of Des1 by 3-ketobases is caused by their dihydroceramide metabolites. However, this effect contributes to increasing dihydrosphingolipid levels only at short incubation times, since cells respond to long time exposure to 3-ketobases with Des1 overexpression. The translation of these overall effects into cell fate is discussed.
|
Authors | Yadira F Ordóñez, Jèssica González, Carmen Bedia, Josefina Casas, José Luis Abad, Antonio Delgado, Gemma Fabrias |
Journal | Molecular bioSystems
(Mol Biosyst)
Vol. 12
Issue 4
Pg. 1166-73
(Apr 2016)
ISSN: 1742-2051 [Electronic] England |
PMID | 26928714
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ketodihydrosphingosine
- Oxidoreductases
- Sphingosine
|
Topics |
- Autophagy
(drug effects)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Humans
- Metabolic Networks and Pathways
- Oxidoreductases
(antagonists & inhibitors)
- Sphingosine
(analogs & derivatives, metabolism, pharmacology)
|